K-pop

Following Cat's Eye and Manon, Sofia Also Suspends Activities… Group to Continue as a Four-Member Unit for the Time Being

Decided to Take a Break to Recover Mental Health Sofia: "I Will Return in Good Health"

YUN GI BACK
2026-08-08 17:51:51
[Edaily Starin YUN GI BACK Reporter] Sophia, a member of the global girl group KATSEYE, will temporarily suspend her activities to focus on her recovery.
KATSEYE’s Sophia (Photo: HYBE·Geffen Records)

On the 8th, HYBE and Geffen Records announced via the fan platform Weverse, “Sophia will not be participating in scheduled promotional activities for the time being,” adding, “In accordance with medical advice, she plans to focus on getting sufficient rest and treatment to recover her mental health.”
Sophia also shared her feelings directly with fans via social media, saying, “I am learning that health comes first,” and added, “It breaks my heart that I won’t be able to participate in many activities with you, but I will focus on my recovery so I can return in better health.”
The decision on whether Sophia will resume activities will be made after her health is reevaluated this September.
With member Manon having previously suspended her activities for health reasons, Cat’s Eye will continue its activities as a four-member group—consisting of Daniela, Megan, Lara, and Yoonchae—for the time being.

Economy

Corporation

IT·Science

Economy

[Exclusive] HANWHA SOLUTIONS Transfers ‘Hanwha Simaron’ to Hanwha Defense… Expects Financial Improvement and Synergies

HANWHA SOLUTIONS(009830)It has been confirmed that Hanwha Solutions has sold its U.S.-based high-pressure tank manufacturing subsidiary, “Hanwha Cimarron LLC,” to Hanwha Defense USA, the U.S. defense …
2026-11-13 15:37:03

Corporation

Burdened by Raw Material Costs and Voluntary Retirement Expenses… Pulmuone Corporate’s Third-Quarter Operating Profit Down 89.6%

Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
2026-11-13 16:40:27

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02